Crossmark

Emicizumab in Children with Severe Hemophilia A

Crossref DOI link: https://doi.org/10.1007/s12098-024-05263-2

Published Online: 2024-09-25

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Thota, Usha Rani https://orcid.org/0000-0001-8695-0362
Martha, Sreelatha

Ravula, Chaitanya Jyothi

Cherukuri, Nirmala https://orcid.org/0000-0001-5272-5933
License Information

Text and Data Mining valid from 2024-09-25

Version of Record valid from 2024-09-25
More Information

Article History

Received: 21 March 2024

Accepted: 28 August 2024

First Online: 25 September 2024

Declarations

:

: None.